Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial

Autor: Tannir, Nizar M., Msaouel, Pavlos, Ross, Jeremy A., Devine, Catherine E., Chandramohan, Anuradha, Gonzalez, Graciela M. Nogueras, Wang, Xuemei, Wang, Jennifer, Corn, Paul G., Lim, Zita D., Pruitt, Lisa, Karam, Jose A., Wood, Christopher G., Zurita, Amado J.
Zdroj: In European Urology Oncology October 2020 3(5):687-694
Databáze: ScienceDirect
Externí odkaz: